Home
Search results for "hiv"
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load by unknow
pdf | | 2016-06-04 | Author:unknow

( Category: other February 26,2021 )
The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment by unknow
pdf | | 2011-11-11 | Author:unknow

( Category: other February 26,2021 )
Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody by unknow
pdf | | 2015-08-24 | Author:unknow

( Category: other February 26,2021 )
Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents by Tracy L. Hartman & Lu Yang & Robert W. Buckheit Jr
pdf | | 2011-11-11 | Author:Tracy L. Hartman & Lu Yang & Robert W. Buckheit Jr.

( Category: other February 26,2021 )
Nanotech-derived topical microbicides for HIV prevention: The road to clinical development by unknow
pdf | | 2014-12-17 | Author:unknow

( Category: other February 26,2021 )
Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression by unknow
pdf | | 2014-06-02 | Author:unknow

( Category: other February 26,2021 )
Within-host co-evolution of Gag P453L and protease D30NN88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 case by Junko Shibata
pdf | | 2011-03-30 | Author:Junko Shibata

( Category: other February 26,2021 )
HIV protease inhibitors induce metabolic dysfunction in part via increased JNK12 pro-inflammatory signaling in L6 cells by Lindsey D. Bogachus & Lorraine P. Turcotte
pdf | | 2011-11-11 | Author:Lindsey D. Bogachus & Lorraine P. Turcotte

( Category: other February 26,2021 )
Safety and efficacy of tenofovirIQP-0528 combination gels – A dual compartment microbicide for HIV-1 prevention by unknow
pdf | | 2012-11-15 | Author:unknow

( Category: other February 26,2021 )
Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens_ A case series by unknow
pdf | | 2018-03-08 | Author:unknow

( Category: other February 26,2021 )
A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity by unknow
pdf | | 2014-11-11 | Author:unknow

( Category: other February 26,2021 )
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor by unknow
pdf | | 2011-07-09 | Author:unknow

( Category: other February 26,2021 )
Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects by unknow
pdf | | 2019-08-07 | Author:unknow

( Category: other February 26,2021 )
SAMHD1 is active in cycling cells permissive to HIV-1 infection by unknow
pdf | | 2017-04-18 | Author:unknow

( Category: other February 26,2021 )
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients_ results from a multicenter cohort study by unknow
pdf | | 2019-08-07 | Author:unknow

( Category: other February 26,2021 )

First Prev [66] [67] [68] [69] 70 [71] [72] [73] [74] [75] [76] Next Last